
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised an extension to the indication for Lynkuet (elinzanetant), allowing its …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

